🔥🐔 BizChicken 🐔🔥
Companies Similar to Compass Therapeutics, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
CytomX Therapeutics, Inc.
Probody technology platform
Cytom X Therapeutics, Inc. is an oncology-focused biopharmaceutical company that develops antibody therapeutics based on its Probody technology platform for treating cancer. Its product candidates include CX-2009, CX-2029, BMS-986249, BMS-986288, CX-2043, and CX-904, targeting various cancers and currently in clinical trials.
Symbol: CTMX
Recent Price: $1.02
Industry: Biotechnology
CEO: Dr. Sean A. McCarthy DPHIL
Sector: Healthcare
Employees: 120
Address: 151 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 515 3185
Last updated: 2024-12-31
Candel Therapeutics, Inc.
CAN-2409, CAN-3110
Candel Therapeutics, Inc. is a clinical stage biopharmaceutical company focused on developing immunotherapies for cancer patients, with products like CAN-2409 and CAN-3110 in various clinical trial phases.
About | About | About | About | Contact | Careers | Careers | About | About | About | Careers | About
Symbol: CADL
Recent Price: $7.95
Industry: Biotechnology
CEO: Dr. Paul-Peter Tak FOCIS, M.D., Ph.D.
Sector: Healthcare
Employees: 42
Address: 117 Kendrick Street, Needham, MA 02494
Phone: 617 916 5445
Last updated: 2024-12-31
Oncternal Therapeutics, Inc.
zilovertamab, ONCT-216, ONCT-808, ONCT-534
Oncternal Therapeutics, Inc. is a clinical-stage biopharmaceutical company specializing in oncology therapies for cancers with significant unmet medical needs, featuring a pipeline that includes the monoclonal antibody zilovertamab and various other targeted treatments.
Symbol: ONCT
Recent Price: $0.53
Industry: Biotechnology
CEO: Dr. James B. Breitmeyer M.D., Ph.D.
Sector: Healthcare
Employees: 27
Address: 12230 El Camino Real, San Diego, CA 92130
Phone: 858 434 1113
Last updated: 2024-12-31
Syndax Pharmaceuticals, Inc.
SNDX-5613, SNDX-6352 (axatilimab), Entinostat
Syndax Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing therapies for cancer treatment, including innovative candidates like SNDX-5613 and SNDX-6352. It collaborates with notable institutions like the National Cancer Institute and has a license agreement with Kyowa Hakko Kirin Co., Ltd.
Symbol: SNDX
Recent Price: $12.52
Industry: Biotechnology
CEO: Mr. Michael A. Metzger M.B.A.
Sector: Healthcare
Employees: 184
Address: 35 Gatehouse Drive, Waltham, MA 02451
Phone: 781 419 1400
Last updated: 2024-12-31
Pyxis Oncology, Inc.
PYX-106, PYX-102, PYX-201, PYX-202, PYX-203
Pyxis Oncology, Inc., a preclinical stage biopharmaceutical company, focuses on developing therapies to treat various cancers through immune-oncology and antibody drug conjugate product candidates.
Symbol: PYXS
Recent Price: $1.56
Industry: Biotechnology
CEO: Dr. Lara S. Sullivan M.D., MBA
Sector: Healthcare
Employees: 55
Address: 35 Cambridgepark Drive, Cambridge, MA 02140
Phone: 617 221 9059
Last updated: 2024-12-31
Tonix Pharmaceuticals Holding Corp.
TNX-1500, TNX-2900, TNX-801, TNX-1840, TNX-1850, TNX-3500
Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company that focuses on developing therapies for immunology, rare diseases, infectious diseases, and central nervous system disorders. Key products include TNX-1500 for organ transplant and autoimmune diseases, TNX-2900 for Prader-Willi syndrome, and TNX-801 for smallpox prevention.
Symbol: TNXP
Recent Price: $0.36
Industry: Biotechnology
CEO: Dr. Seth Lederman M.D.
Sector: Healthcare
Employees: 103
Address: 26 Main Street, Chatham, NJ 07928
Phone: 862 799 8599
Last updated: 2024-12-31
Black Diamond Therapeutics, Inc.
BDTX-189, BDTX-1535, BDTX-4933
Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.
Symbol: BDTX
Recent Price: $2.15
Industry: Biotechnology
CEO: Dr. Mark A. Velleca M.D., Ph.D.
Sector: Healthcare
Employees: 54
Address: One Main Street, Cambridge, MA 02142
Phone: 617 252 0848
Leadership
- Ali Behbahani, M.D., Co-Head of Healthcare, NEA
- Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
- Kapil Dhingra, M.D., Former Head, Roche Oncology Development
- Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
- Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
- Prakash Raman, Ph.D., CEO of InduPro, Inc.
- Mark A. Velleca, M.D., Ph.D., CEO and Board Chair
Last updated: 2024-12-31
Checkpoint Therapeutics, Inc.
Cosibelimab
Checkpoint Therapeutics, Inc. is a clinical-stage immunotherapy and targeted oncology company focused on acquiring, developing, and commercializing novel treatments for solid tumor cancers. Their lead product candidates include Cosibelimab, a fully-human monoclonal antibody, and other treatments for various cancer targets.
Symbol: CKPT
Recent Price: $3.35
Industry: Biotechnology
CEO: Mr. James F. Oliviero III, C.F.A.
Sector: Healthcare
Employees: 23
Address: 95 Sawyer Road, Waltham, MA 02453
Phone: 781 652 4500
Last updated: 2024-12-31
Celldex Therapeutics, Inc.
therapeutic monoclonal and bispecific antibodies
Celldex Therapeutics is a biopharmaceutical company focused on developing therapeutic monoclonal and bispecific antibodies for treating inflammatory diseases and cancers.
About | About | Management | Directors | About | Contact | About | Contact | Careers | Careers | Careers | Careers | Jobs | Careers | About | About
Symbol: CLDX
Recent Price: $25.12
Industry: Biotechnology
CEO: Mr. Anthony S. Marucci M.B.A.
Sector: Healthcare
Employees: 160
Address: Perryville III Building, Hampton, NJ 08827
Phone: 908 200 7500
Leadership
- Anthony S. Marucci, Founder, President, Chief Executive Officer and Director
- Tibor Keler, Ph.D., Founder, Executive Vice President and Chief Scientific Officer
- Diane C. Young, M.D., Senior Vice President and Chief Medical Officer
- Elizabeth Crowley, Senior Vice President, Chief Product Development Officer
- Sam Martin, Senior Vice President and Chief Financial Officer
- Ronald A. Pepin, Ph.D., Senior Vice President and Chief Business Officer
- Richard Wright, Ph.D., Senior Vice President and Chief Commercial Officer
- Sarah Cavanaugh, Senior Vice President, Corporate Affairs and Administration
- Margo Heath-Chiozzi, M.D., Senior Vice President, Regulatory Affairs
- Freddy A. Jimenez, Esq., Senior Vice President and General Counsel
- Karen L. Shoos, J.D., Former Chair, Director of Operations, Maryland Tech Council Venture Mentoring Services Program
- Keith L. Brownlie, Former Partner, Ernst & Young LLP
- Herbert J. Conrad, Former President, Roche Pharmaceuticals US
- James J. Marino, J.D., Former Partner, Dechert LLP
- Harry H. Penner, Jr., J.D., L.L.M., Former Chairman and CEO, Nascent Bioscience
- Cheryl L. Cohen, President, CLC Consulting; Former Chief Commercial Officer of Medivation, Inc.
- Dr. Garry Neil, Chief Executive Officer; Chair of the Board, Avalo Therapeutics
- Rita Jain, M.D., Former Executive Vice President, Chief Medical Officer of ChemoCentryx, Inc.
- Carl June, M.D.,
- Michel Nussenzweig, M.D., Ph.D.,
- Marc E. Rothenberg M.D., Ph.D.,
- Joseph Schlessinger, Ph.D.,
- Louis Weiner, M.D.,
Last updated: 2024-12-31
Compass Therapeutics, Inc.
CTX-009, CTX-471, CTX-8371
Compass Therapeutics, Inc. is a clinical-stage oncology-focused biopharmaceutical company developing antibody-based therapeutics to treat various human diseases. Their clinical stage products include investigational bispecific antibodies like CTX-009 and monoclonal antibodies such as CTX-471.
Symbol: CMPX
Recent Price: $1.48
Industry: Biotechnology
CEO: Dr. Thomas J. Schuetz M.D., Ph.D.
Sector: Healthcare
Employees: 32
Address: 80 Guest Street, Boston, MA 02135
Phone: 617 500 8099
Last updated: 2024-12-31
Context Therapeutics Inc.
onapristone extended release (ONA-XR)
Context Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on developing cancer treatments for women in the United States. Its main product, ONA-XR, is aimed at resistant female hormone-dependent cancers.
Symbol: CNTX
Recent Price: $1.06
Industry: Biotechnology
CEO: Mr. Martin A. Lehr
Sector: Healthcare
Employees: 5
Address: 2001 Market Street, Philadelphia, PA 19103
Phone: 267 225 7416
Last updated: 2024-12-31
Cogent Biosciences, Inc.
CGT9486
Cogent Biosciences, Inc. is a biotechnology company focused on developing precision therapies for genetically defined diseases, with lead product candidate CGT9486 targeting mutations driving systemic mastocytosis and advanced gastrointestinal stromal tumors.
Symbol: COGT
Recent Price: $7.67
Industry: Biotechnology
CEO: Mr. Andrew R. Robbins M.B.A.
Sector: Healthcare
Employees: 164
Address: 200 Cambridge Park Drive, Cambridge, MA 02140
Phone: 617 945 5576
Last updated: 2024-12-31
Intensity Therapeutics, Inc.
INT230-6
Intensity Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the discovery, development, and commercialization of cancer drugs for treating solid tumors. Their lead product, INT230-6, is undergoing Phase 2 trials for various cancers and is being tested in collaborations with major pharmaceutical companies.
Symbol: INTS
Recent Price: $1.82
Industry: Biotechnology
CEO: Mr. Lewis H. Bender M.A., M.B.A., M.S.
Sector: Healthcare
Employees: 5
Address: 61 Wilton Road, Westport, CT 06880
Phone: 203 221 7381
Leadership
- Lewis H. Bender, M.S., M.A., M.B.A., Founder and CEO
- Joseph Talamo, CPA, Chief Financial Officer
- James M. Ahlers, Executive Vice President
- Brian Schwartz, MD, Executive VP, Clinical Development
- John Wesolowski, CPA, MBA, Principal Accounting Officer and Controller
- Kimberly A. Guedes, RN, MBA, Vice President of Clinical Operations
- Doranne Frano, Regulatory Affairs and Quality Control
- Daniel J. Donovan, Board Member and Chief Executive Officer
- Tom Dubin, Board Member
- Mark A. Goldberg, MD, Board Member
- Emer Leahy, Ph.D., Board Member
Last updated: 2024-12-31
Nurix Therapeutics, Inc.
NX-2127, NX-5948, NX-1607, NX-0255
Nurix Therapeutics, Inc. is a biopharmaceutical company that focuses on developing small molecule therapies for cancer and immune disorders, with products targeting BTK and CBL-B proteins. The company collaborates with Gilead Sciences and Sanofi.
Symbol: NRIX
Recent Price: $18.64
Industry: Biotechnology
CEO: Dr. Arthur T. Sands M.D., Ph.D.
Sector: Healthcare
Employees: 284
Address: 1700 Owens Street, San Francisco, CA 94158
Phone: 415 660 5320
Last updated: 2024-12-31
TransCode Therapeutics, Inc.
TTX-MC138
Trans Code Therapeutics, Inc. is a biopharmaceutical company focused on developing and commercializing drugs and diagnostics for treating metastatic disease. Their lead product, TTX-MC138, is aimed at metastatic cancer treatment, along with a range of other therapeutic platforms targeting cancer through innovative RNA- and CRISPR-based technologies.
Symbol: RNAZ
Recent Price: $3.76
Industry: Biotechnology
CEO: Mr. Thomas A. Fitzgerald M.B.A.
Sector: Healthcare
Employees: 10
Address: 6 Liberty Square, Boston, MA 02109
Phone: 857-837-3099
Last updated: 2024-12-31
TRACON Pharmaceuticals, Inc.
therapeutics for cancer
TRACON Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing cancer therapeutics, including clinical stage products like envafolimab, YH001, TRC102, and TJ004309, with collaboration agreements with various biopharmaceutical companies.
Symbol: TCON
Recent Price: $0.03
Industry: Biotechnology
CEO: Mr. Craig R. Jalbert CIRA
Sector: Healthcare
Employees: 17
Address: 4350 La Jolla Village Drive, San Diego, CA 92122
Phone: 858 550 0780
Last updated: 2024-12-31
XBiotech Inc.
True Human monoclonal antibodies
XBiotech Inc. discovers, develops, and commercializes True Human monoclonal antibodies targeting inflammatory and infectious diseases, with additional development in interleukin-1 alpha therapies for various medical conditions and COVID-19 therapy.
Symbol: XBIT
Recent Price: $4.09
Industry: Biotechnology
CEO: Mr. John Simard
Sector: Healthcare
Employees: 94
Address: 5217 Winnebago Lane, Austin, TX 78744
Phone: 512 386 2900
Last updated: 2024-12-31
Xilio Therapeutics, Inc.
XTX101
Xilio Therapeutics, Inc., a clinical-stage biotechnology company, develops immunotherapies to improve the immune system of cancer patients with a focus on tumor-selective therapies.
Symbol: XLO
Recent Price: $0.97
Industry: Biotechnology
CEO: Dr. Rene Russo BCPS, Pharm.D.
Sector: Healthcare
Employees: 73
Address: 828 Winter Street, Waltham, MA 02451
Phone: 617 430 4680
Last updated: 2024-12-31
Xencor, Inc.
Monoclonal Antibody and Cytokine Therapeutics
Xencor, Inc. is a clinical-stage biopharmaceutical company specializing in the discovery and development of engineered monoclonal antibody and cytokine therapeutics for treating cancer and autoimmune diseases.
About | ESG | Contact | Careers | Careers | About | Events | About | About | About | Contact | Management | About | Directors | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | About | Careers
Symbol: XNCR
Recent Price: $23.71
Industry: Biotechnology
CEO: Dr. Bassil I. Dahiyat Ph.D.
Sector: Healthcare
Employees: 280
Address: 111 West Lemon Avenue, Monrovia, CA 91016
Phone: 626 305 5900
Last updated: 2024-12-31
Exelixis, Inc.
CABOMETYX, COMETRIQ, COTELLIC, MINNEBRO
Exelixis, Inc. is an oncology-focused biotechnology company that discovers, develops, and commercializes new medicines to treat cancers, primarily in the United States. Its products include CABOMETYX, COMETRIQ, COTELLIC, and MINNEBRO.
Contact | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | Careers
Symbol: EXEL
Recent Price: $33.70
Industry: Biotechnology
CEO: Dr. Michael M. Morrissey Ph.D.
Sector: Healthcare
Employees: 1310
Address: 1851 Harbor Bay Parkway, Alameda, CA 94502
Phone: 650 837 7000
Last updated: 2024-12-31